Shuttle Pharmaceuticals (NASDAQ:SHPH) Shares Down 2.1% – What’s Next?

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH)’s share price traded down 2.1% during mid-day trading on Wednesday . The stock traded as low as $3.31 and last traded at $3.34. 10,641 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 33,414 shares. The stock had previously closed at $3.41.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen cut shares of Shuttle Pharmaceuticals to a “strong sell” rating in a research report on Saturday, June 21st.

Shuttle Pharmaceuticals Stock Performance

The stock has a market cap of $3.57 million, a P/E ratio of -0.80 and a beta of -1.08. The firm’s 50 day moving average is $3.71 and its 200 day moving average is $7.15.

Shuttle Pharmaceuticals Company Profile

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .